Blood pressure variability in acute stroke: Risk factors and association with functional outcomes at 1 month.
blood pressure
blood pressure variability
functional outcomes
sodium
stroke
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
13 May 2024
13 May 2024
Historique:
revised:
02
04
2024
received:
21
02
2024
accepted:
08
04
2024
medline:
13
5
2024
pubmed:
13
5
2024
entrez:
13
5
2024
Statut:
aheadofprint
Résumé
Blood pressure variability, in acute stroke, may be an important modifiable determinant of functional outcome after stroke. In a large international cohort of participants with acute stroke, it was sought to determine the association of blood pressure variability (in the early period of admission) and functional outcomes, and to explore risk factors for increased blood pressure variability. INTERSTROKE is an international case-control study of risk factors for first acute stroke. Blood pressure was recorded at the time of admission, the morning after admission and the time of interview in cases (median time from admission 36.7 h). Multivariable ordinal regression analysis was employed to determine the association of blood pressure variability (standard deviation [SD] and coefficient of variance) with modified Rankin score at 1-month follow-up, and logistic regression was used to identify risk factors for blood pressure variability. Amongst 13,206 participants, the mean age was 62.19 ± 13.58 years. When measured by SD, both systolic blood pressure variability (odds ratio 1.13; 95% confidence interval 1.03-1.24 for SD ≥20 mmHg) and diastolic blood pressure variability (odds ratio 1.15; 95% confidence interval 1.04-1.26 for SD ≥10 mmHg) were associated with a significant increase in the odds of poor functional outcome. The highest coefficient of variance category was not associated with a significant increase in risk of higher modified Rankin score at 1 month. Increasing age, female sex, high body mass index, history of hypertension, alcohol use, and high urinary potassium and low urinary sodium excretion were associated with increased blood pressure variability. Increased blood pressure variability in acute stroke, measured by SD, is associated with an increased risk of poor functional outcome at 1 month. Potentially modifiable risk factors for increased blood pressure variability include low urinary sodium excretion.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Blood pressure variability, in acute stroke, may be an important modifiable determinant of functional outcome after stroke. In a large international cohort of participants with acute stroke, it was sought to determine the association of blood pressure variability (in the early period of admission) and functional outcomes, and to explore risk factors for increased blood pressure variability.
PATIENTS AND METHODS
METHODS
INTERSTROKE is an international case-control study of risk factors for first acute stroke. Blood pressure was recorded at the time of admission, the morning after admission and the time of interview in cases (median time from admission 36.7 h). Multivariable ordinal regression analysis was employed to determine the association of blood pressure variability (standard deviation [SD] and coefficient of variance) with modified Rankin score at 1-month follow-up, and logistic regression was used to identify risk factors for blood pressure variability.
RESULTS
RESULTS
Amongst 13,206 participants, the mean age was 62.19 ± 13.58 years. When measured by SD, both systolic blood pressure variability (odds ratio 1.13; 95% confidence interval 1.03-1.24 for SD ≥20 mmHg) and diastolic blood pressure variability (odds ratio 1.15; 95% confidence interval 1.04-1.26 for SD ≥10 mmHg) were associated with a significant increase in the odds of poor functional outcome. The highest coefficient of variance category was not associated with a significant increase in risk of higher modified Rankin score at 1 month. Increasing age, female sex, high body mass index, history of hypertension, alcohol use, and high urinary potassium and low urinary sodium excretion were associated with increased blood pressure variability.
CONCLUSION
CONCLUSIONS
Increased blood pressure variability in acute stroke, measured by SD, is associated with an increased risk of poor functional outcome at 1 month. Potentially modifiable risk factors for increased blood pressure variability include low urinary sodium excretion.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e16314Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© 2024 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Lee M, Ovbiagele B, Hong KS, et al. Effect of blood pressure lowering in early ischemic stroke: meta‐analysis. Stroke. 2015;46(7):1883‐1889. doi:10.1161/STROKEAHA.115.009552
Yang P, Song L, Zhang Y, et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open‐label, blinded‐endpoint, randomised controlled trial. Lancet. 2022;400(10363):1585‐1596. doi:10.1016/S0140-6736(22)01882-7
Mazighi M, Richard S, Lapergue B, et al. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP‐TARGET): a multicentre, open‐label, randomised controlled trial. Lancet Neurol. 2021;20(4):265‐274. doi:10.1016/S1474-4422(20)30483-X
Nam HS, Kim YD, Heo J, et al. Intensive vs conventional blood pressure lowering after endovascular thrombectomy in acute ischemic stroke: the OPTIMAL‐BP randomized clinical trial. JAMA. 2023;330(9):832‐842. doi:10.1001/jama.2023.14590
Ma L, Hu X, Song L, et al. The third intensive care bundle with blood pressure reduction in acute cerebral haemorrhage trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. Lancet. 2023;402(10395):27‐40. doi:10.1016/S0140-6736(23)00806-1
Bang OY, Chung JW, Kim SK, et al. Therapeutic‐induced hypertension in patients with noncardioembolic acute stroke. Neurology. 2019;93(21):e1955‐e1963. doi:10.1212/WNL.0000000000008520
Nasi LA, Martins SCO, Gus M, et al. Early manipulation of arterial blood pressure in acute ischemic stroke (MAPAS): results of a randomized controlled trial. Neurocrit Care. 2019;30(2):372‐379. doi:10.1007/s12028-018-0642-5
Boulouis G, Morotti A, Goldstein JN, Charidimou A. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta‐analysis of randomised trials. J Neurol Neurosurg Psychiatry. 2017;88(4):339‐345. doi:10.1136/jnnp-2016-315346
Moullaali TJ, Wang X, Sandset EC, et al. Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta‐analysis of individual patient data. J Neurol Neurosurg Psychiatry. 2022;93(1):6‐13. doi:10.1136/jnnp-2021-327195
Liu L, Xie X, Pan Y, et al. Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial. BMJ. 2023;383:e076448. doi:10.1136/bmj-2023-076448
Sandset EC, Anderson CS, Bath PM, et al. European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. Eur Stroke J. 2021;6(2):XLVIII‐LXXXIX. doi:10.1177/23969873211012133
Wang H, Li M, Xie S, et al. Visit‐to‐visit systolic blood pressure variability and stroke risk: a systematic review and meta‐analysis. CURR Med SCI. 2019;39(5):741‐747. doi:10.1007/s11596-019-2100-9
Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit‐to‐visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375(9718):895‐905. doi:10.1016/S0140-6736(10)60308-X
Manning LS, Mistri AK, Potter J, Rothwell PM, Robinson TG. Short‐term blood pressure variability in acute stroke: post hoc analysis of the controlling hypertension and hypotension immediately post stroke and continue or stop post‐stroke antihypertensives collaborative study trials. Stroke. 2015;46(6):1518‐1524. doi:10.1161/STROKEAHA.115.009078
Yang C, Liu K, Song Y, et al. Day‐by‐day blood pressure variability is associated with neurological functional outcome after acute ischemic stroke. Front Neurol. 2020;11:566825. doi:10.3389/fneur.2020.566825
Kollias A, Stergiou GS, Kyriakoulis KG, Bilo G, Parati G. Treating visit‐to‐visit blood pressure variability to improve prognosis: is amlodipine the drug of choice? Hypertension. 2017;70(5):862‐866. doi:10.1161/HYPERTENSIONAHA.117.10087
Havlik RJ, Foley DJ, Sayer B, Masaki K, White L, Launer LJ. Variability in midlife systolic blood pressure is related to late‐life brain white matter lesions: the Honolulu–Asia aging study. Stroke. 2002;33(1):26‐30. doi:10.1161/hs0102.101890
Stevens SL, Wood S, Koshiaris C, et al. Blood pressure variability and cardiovascular disease: systematic review and meta‐analysis. BMJ. 2016;354:i4098. doi:10.1136/bmj.i4098
Judge C, O'Donnell MJ, Hankey GJ, et al. Urinary sodium and potassium, and risk of ischemic and hemorrhagic stroke (INTERSTROKE): a case–control study. Am J Hypertens. 2021;34(4):414‐425. doi:10.1093/ajh/hpaa176
O'Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case–control study. Lancet. 2016;388(10046):761‐775. doi:10.1016/S0140-6736(16)30506-2
Dehghan M, Mente A, Teo KK, et al. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high‐risk individuals from 40 countries. Circulation. 2012;126(23):2705‐2712. doi:10.1161/CIRCULATIONAHA.112.103234
Tanaka T, Okamura T, Miura K, et al. A simple method to estimate populational 24‐h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16(2):97‐103. doi:10.1038/sj.jhh.1001307
Mente A, O'Donnell MJ, Dagenais G, et al. Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24‐h measures in 11 countries. J Hypertens. 2014;32(5):1005‐1015. doi:10.1097/HJH.0000000000000122
Elm E von, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335(7624):806–808. doi:10.1136/bmj.39335.541782.AD
Shrestha N. Detecting multicollinearity in regression analysis. AJAMS. 2020;8(2):39‐42. doi:10.12691/ajams-8-2-1
Sun F, Zhao LP, Zhang JY, Jin C, Jin Q. The effects of dietary salt on blood pressure variability, cerebral perfusion and cognitive function in young‐adult male rats. Phys Ther. 2023;38(S1):5732586. doi:10.1152/physiol.2023.38.S1.5732586
Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883‐1948. doi:10.1093/eurheartj/ehy037
Palaiodimou L, Joundi RA, Katsanos AH, et al. Association between blood pressure variability and outcomes after endovascular thrombectomy for acute ischemic stroke: an individual patient data meta‐analysis. Eur Stroke J. 2024;9(1):88‐96. doi:10.1177/23969873231211157
Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364‐e467. doi:10.1161/STR.0000000000000375
Zhou TL, Schütten MTJ, Kroon AA, et al. Urinary sodium excretion and salt intake are not associated with blood pressure variability in a white general population. JAHA. 2023;12(1):e026578. doi:10.1161/JAHA.122.026578
Schutte R, Thijs L, Liu YP, et al. Within‐subject blood pressure level—not variability—predicts fatal and nonfatal outcomes in a general population. Hypertension. 2012;60(5):1138‐1147. doi:10.1161/HYPERTENSIONAHA.112.202143
De La Sierra A, Redon J, Banegas JR, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009;53(3):466‐472. doi:10.1161/HYPERTENSIONAHA.108.124008
Gosmanova EO, Mikkelsen MK, Molnar MZ, et al. Association of systolic blood pressure variability with mortality, coronary heart disease, stroke, and renal disease. J Am Coll Cardiol. 2016;68(13):1375‐1386. doi:10.1016/j.jacc.2016.06.054
Webb AJ, Lawson A, Mazzucco S, Li L, Rothwell PM. Age and sex distribution of beat‐to‐beat blood pressure variability after transient ischemic attack and minor stroke: a population‐based study. Int J Stroke. 2021;16(6):683‐691. doi:10.1177/1747493020971905
Parati G, Bilo G, Kollias A, et al. Blood pressure variability: methodological aspects, clinical relevance and practical indications for management—a European Society of Hypertension position paper*. J Hypertens. 2023;41(4):527‐544. doi:10.1097/HJH.0000000000003363